Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-29 4:32 pm Purchase | 2025-07-23 | 13G | DEFSEC Technologies Inc. DFSC | Mitchell P. Kopin | 71,693 4.990% | 71,693 (New Position) | Filing History |
| 2025-07-23 5:03 pm Purchase | 2025-07-17 | 13G | Draganfly Inc. DPRO | Mitchell P. Kopin | 990,228 4.990% | 320,074 (+47.76%) | Filing History |
| 2025-07-18 5:46 pm Purchase | 2025-07-15 | 13G | Soluna Holdings, Inc. SLNH | Mitchell P. Kopin | 2,997,785 9.990% | 2,997,785 (New Position) | Filing History |
| 2025-07-18 5:46 pm Purchase | 2025-07-15 | 13G | 60 Degrees Pharmaceuticals, Inc. SXTP | Mitchell P. Kopin | 372,429 9.990% | 295,071 (+381.43%) | Filing History |
| 2025-07-09 4:31 pm Purchase | 2025-07-02 | 13G | Netcapital Inc. NCPL | Mitchell P. Kopin | 287,877 7.100% | 287,877 (New Position) | Filing History |
| 2025-07-09 4:29 pm Purchase | 2025-07-02 | 13G | Actelis Networks, Inc. ASNS | Mitchell P. Kopin | 81,301 7.600% | 81,301 (New Position) | Filing History |
| 2025-07-08 5:02 pm Purchase | 2025-07-01 | 13G | GeoVax Labs, Inc. GOVX | Mitchell P. Kopin | 2,792,404 9.990% | 2,792,404 (New Position) | Filing History |
| 2025-07-08 5:02 pm Purchase | 2025-07-01 | 13G | Cellectar Biosciences, Inc. CLRB | Mitchell P. Kopin | 140,101 4.990% | 140,101 (New Position) | Filing History |
| 2025-07-03 5:25 pm Purchase | 2025-06-27 | 13G | Bone Biologics Corporation BBLG | Mitchell P. Kopin | 153,219 9.990% | 153,219 (New Position) | Filing History |
| 2025-07-03 5:24 pm Purchase | 2025-06-27 | 13G | Ascent Solar Technologies, Inc. Common Stock ASTI | Mitchell P. Kopin | 317,830 9.990% | 317,830 (New Position) | Filing History |
| 2025-07-01 4:44 pm Purchase | 2025-06-25 | 13G | Lifeward Ltd. LFWD | Mitchell P. Kopin | 819,443 4.990% | 265,622 (+47.96%) | Filing History |
| 2025-06-27 5:08 pm Purchase | 2025-06-20 | 13G | SeaStar Medical Holding Corporation ICU | Mitchell P. Kopin | 1,803,026 9.990% | 1,803,026 (New Position) | Filing History |
| 2025-06-25 4:38 pm Unchanged | 2025-06-18 | 13G | Aptevo Therapeutics Inc. APVO | Mitchell P. Kopin | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-06-23 06:03 am Purchase | 2025-06-17 | 13G | Processa Pharmaceuticals, Inc. PCSA | Mitchell P. Kopin | 3,018,238 9.990% | 3,018,238 (New Position) | Filing History |
| 2025-06-23 06:03 am Purchase | 2025-06-17 | 13G | Adial Pharmaceuticals, Inc. ADIL | Mitchell P. Kopin | 446,282 2.800% | 446,282 (New Position) | Filing History |
| 2025-06-13 5:31 pm Purchase | 2025-06-06 | 13G | Venus Concept Inc. VERO | Mitchell P. Kopin | 120,474 4.990% | 82,698 (+218.92%) | Filing History |
| 2025-06-13 5:31 pm Purchase | 2025-06-09 | 13G | Nuwellis, Inc. NUWE | Mitchell P. Kopin | 5,978 4.990% | 5,978 (New Position) | Filing History |
| 2025-06-13 5:30 pm Purchase | 2025-06-11 | 13G | Draganfly Inc. DPRO | Mitchell P. Kopin | 670,154 4.990% | 670,154 (New Position) | Filing History |
| 2025-05-30 5:12 pm Purchase | 2025-05-28 | 13G | Imunon, Inc. IMNN | Mitchell P. Kopin | 74,074 5.500% | 74,074 (New Position) | Filing History |
| 2025-05-27 5:30 pm Purchase | 2025-05-20 | 13G | Jaguar Health, Inc. JAGX | Mitchell P. Kopin | 65,002 4.990% | 65,002 (New Position) | Filing History |